Breakthrough, historic and game changing news showing impressive reductions in the degree of obesity in adolescents aged 12-17 years with once weekly #semaglutide 2.4 mg. We need to have the conversation to provide chronic care #OW2022 @novonordisk
Aramak "OW2022"
Son-
-
Adsence2 Sponsorluğunda:📢 Sponsorluğunda: -
“Crazy Good.” That's how pediatric obesity medicine researcher Aaron Kelly described the results with #semaglutide for treating obesity in #adolescents presented yesterday at #OW2022 and published in @NEJM. https://foxdeo.com/94te.tnk
-
Therapeutic options for management of #obesity are limited and often challenging in adolescents. Semaglutide appears to represent a useful strategy to consider for some young people living with and impacted by #obesity #weightloss #OW2022
-
Postbariatric weight recurrence is common! Visit our poster to find out if #semaglutide or #liraglutide was more effective after #bariatric surgery. #Obesity is a chronic disease and we need to treat it! #OW2022 @ObesitySociety @sarahmessiah @obsmcha
1